Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Channel Rhodopsins01:11

Channel Rhodopsins

2.6K
Most organisms use photoreceptors to sense and respond to light. Examples of photoreceptors include bacteriorhodopsins and bacteriophytochromes in some bacteria, phytochromes in plants, and rhodopsins in the photoreceptor cells of the vertebral retina. The light-sensitive property of these receptors is because of the bound chromophores, such as bilin in the phytochromes and retinal in the rhodopsins.
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
2.6K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells.

ACS omega·2026
Same author

The Chemical Stability Characterization and Kinetics of Statins in Aqueous Cyclodextrin Ocular Preparations: A Formulation Perspective.

Pharmaceutics·2025
Same author

H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration.

Communications medicine·2025
Same author

Antimicrobial Preservatives in Cyclodextrin-Containing Drug Formulations.

Pharmaceutics·2025
Same author

H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration.

bioRxiv : the preprint server for biology·2024
Same author

Molecular mechanisms underlying inherited photoreceptor degeneration as targets for therapeutic intervention.

Frontiers in cellular neuroscience·2024

Related Experiment Video

Updated: Jun 27, 2025

Organotypic Retinal Explant Cultures from Macaque Monkey
10:32

Organotypic Retinal Explant Cultures from Macaque Monkey

Published on: August 24, 2022

1.3K

New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration.

Oswaldo Pérez1,2, Agnese Stanzani3, Li Huang3

  • 1Chemical Processes and Pharmaceutical Development Research Institutes of Sweden, Forskargatan 20 J, 15136 Södertälje, Sweden.

Journal of Medicinal Chemistry
|April 30, 2024
PubMed
Summary

Dithio-CN03, a novel cyclic guanosine monophosphate (cGMP) analogue, shows significant neuroprotective effects in retinitis pigmentosa (RP) models. This compound demonstrates higher efficacy than existing candidates, offering a promising new therapeutic avenue for RP treatment.

More Related Videos

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
09:05

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina

Published on: May 6, 2015

10.8K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K

Related Experiment Videos

Last Updated: Jun 27, 2025

Organotypic Retinal Explant Cultures from Macaque Monkey
10:32

Organotypic Retinal Explant Cultures from Macaque Monkey

Published on: August 24, 2022

1.3K
Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
09:05

Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina

Published on: May 6, 2015

10.8K
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K

Area of Science:

  • Medicinal Chemistry
  • Ophthalmology
  • Neuroscience

Background:

  • Retinitis pigmentosa (RP) causes retinal degeneration, particularly in young individuals, with a significant unmet medical need.
  • Elevated cyclic guanosine monophosphate (cGMP) levels are implicated in photoreceptor degeneration, suggesting cGMP analogues as potential therapeutics.

Purpose of the Study:

  • To synthesize and evaluate dithio-CN03, a novel phosphorodithioate analogue of cGMP, for its therapeutic potential in retinitis pigmentosa.
  • To compare the neuroprotective efficacy of dithio-CN03 against related compounds in in vitro models of RP.

Main Methods:

  • Synthesis of dithio-CN03 using the H-phosphonothioate route.
  • Characterization of dithio-CN03 crystal modifications (trihydrate and tetrahydrofuran monosolvate).
  • In vitro testing of neuroprotective effects in photoreceptor models of RP, comparing dithio-CN03 with CN03, SP-CN03, and oxo-CN03.

Main Results:

  • Dithio-CN03 was successfully synthesized and characterized.
  • Dithio-CN03 exhibited lower aqueous solubility than CN03, potentially beneficial for sustained retinal delivery.
  • Dithio-CN03 demonstrated superior neuroprotective efficacy compared to CN03, SP-CN03, and oxo-CN03 in RP photoreceptor models.

Conclusions:

  • Dithio-CN03 is a highly effective neuroprotective agent for photoreceptor degeneration.
  • The compound represents a promising new therapeutic candidate for treating retinitis pigmentosa.
  • Its favorable physicochemical properties may enhance retinal drug delivery formulations.